MDT vs ZBIO · P/E 21, rev $36.36B vs rev $10.0M
Medtronic PLC (MDT) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the MDT and ZBIO stock pages for the full models.
Not investment advice.